Soliton, Inc. (SOLY)

Dec 16, 2021 - SOLY was delisted (reason: acquired by Allergan Aesthetics)
22.58
0.03 (0.13%)
At close: Dec 15, 2021 4:00 PM
22.59
0.01 (0.04%)
After-hours:Dec 15, 2021 7:05 PM EST
Market Cap487.65M
Revenue (ttm)370,000
Net Income (ttm)-17.88M
Shares Out21.60M
EPS (ttm)-0.84
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,347,169
Open22.56
Previous Close22.55
Day's Range22.56 - 22.59
52-Week Range7.40 - 22.60
Beta0.18
AnalystsHold
Price Target22.60 (+0.1%)
Earnings DateNov 18, 2021

About SOLY

Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas.

IndustryHealth Care Equipment & Supplies
IPO DateFeb 19, 2019
Employees13
Stock ExchangeNASDAQ
Ticker SymbolSOLY
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for Soliton stock is "Hold." The 12-month stock price forecast is 22.60, which is an increase of 0.09% from the latest price.

Price Target
$22.60
(0.09% upside)
Analyst Consensus: Hold

News

Allergan Aesthetics Completes Acquisition of Soliton

IRVINE, Calif., Dec. 16, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the successful completion of its acquisition of Soliton, Inc. (NASDAQ: SOLY).

Other symbols:ABBV
1 month ago - PRNewsWire

Why Soliton Popped While the Market Slid Today

The company's absorption into AbbVie will apparently occur very, very soon.

1 month ago - The Motley Fool

INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to...

NEW YORK , July 10, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM)  concerning pot...

Other symbols:ONEM
6 months ago - PRNewsWire

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Soliton, Inc. - SOLY

NEW YORK, May 15, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action ...

8 months ago - PRNewsWire

Soliton (SOLY) is in Overbought Territory: What's Next?

Soliton (SOLY) has moved higher as of late, but there could definitely be trouble on the horizon for this company

8 months ago - Zacks Investment Research

SOLITON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of P...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Soliton, Inc. (Nas...

Other symbols:ABBV
8 months ago - Business Wire

Soliton Reports First Quarter 2021 Results

HOUSTON, May 12, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial resu...

8 months ago - PRNewsWire

Shareholder Alert: Ademi LLP investigates whether Soliton, Inc. has obtained a Fair Price in its transaction with AbbVie

MILWAUKEE, May 10, 2021 /PRNewswire/ -- Ademi LLP is investigating Soliton (NASDAQ: SOLY) for possible breaches of fiduciary duty and other violations of law in its transaction with AbbVie. Click here t...

8 months ago - PRNewsWire

SHAREHOLDER ALERT: WeissLaw LLP Investigates Soliton, Inc.

NEW YORK, May 10, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Soliton, Inc. ("Soliton" or the "Company...

Other symbols:ABBV
8 months ago - PRNewsWire

Soliton Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Soliton, Inc. Is Fair...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Soliton, Inc. (NASDAQ: SOLY) to Allergan Aesthetics for $22.60 per share in cash is f...

8 months ago - Business Wire

Soliton Stock Rallies After $22.60/Share Buyout From AbbVie

AbbVie Inc (NYSE: ABBV) is making an opportunistic play to boost the aesthetics business by adding a long-delayed body sculpting product into the fold. AbbVie's Allergan Aesthetics unit will pay $550 mi...

Other symbols:ABBV
8 months ago - Benzinga

Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio

IRVINE, Calif. and HOUSTON, May 10, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) and Soliton (NASDAQ: SOLY) today announced a definitive agreement under which Allergan Aesthe...

Other symbols:ABBV
8 months ago - PRNewsWire

Introducing RESONIC™

HOUSTON, May 5, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the ...

8 months ago - PRNewsWire

Soliton to Report First Quarter 2021 Financial Results on May 13, 2021

HOUSTON, May 4, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the Compa...

8 months ago - PRNewsWire

Soliton Receives FDA Clearance of Special 510(k)

HOUSTON, April 29, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the U.S. Fo...

8 months ago - PRNewsWire

Soliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual Conference

HOUSTON, April 27, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the 52...

8 months ago - PRNewsWire

Soliton Provides Special 510(k) and Commercialization Update

HOUSTON, April 15, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the U....

9 months ago - PRNewsWire

Soliton to Participate in Three Upcoming Healthcare Conferences

HOUSTON, March 11, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced members of ...

10 months ago - PRNewsWire

Soliton Announces Initiation of Second Animal Study for Potential RAP Treatment of Liver Fibrosis

HOUSTON, March 9, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced th...

10 months ago - PRNewsWire

Soliton Reports Fourth Quarter and Full Year 2020 Results

HOUSTON, March 4, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial res...

10 months ago - PRNewsWire

Soliton to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021

HOUSTON, Feb. 22, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the Com...

10 months ago - PRNewsWire

Soliton Named Best New Technology Award at the Aesthetic Industry Association Board Meeting

HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the com...

11 months ago - PRNewsWire

Soliton Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cellulite

HOUSTON, Feb. 1, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced tha...

11 months ago - PRNewsWire

Soliton Announces Collaboration with US Navy to Conduct Proof-of-Concept Study for Fibrotic Scars

HOUSTON, Jan. 26, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced it has enter...

11 months ago - PRNewsWire

Soliton Appoints Sean J. Shapiro as Vice President of Sales

HOUSTON, Dec. 30, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the appointm...

1 year ago - PRNewsWire